Baxter International (NYSE:BAX) Downgraded by Morgan Stanley

Morgan Stanley lowered shares of Baxter International (NYSE:BAX – Free Report) from an equal weight rating to an underweight rating in a research note issued to investors on Monday morning, MarketBeat Ratings reports. Morgan Stanley currently has $30.00 price objective on the medical instruments supplier’s stock, down from their prior price objective of $39.00. A […]

Leave a Reply

Your email address will not be published.

Previous post JPMorgan Chase & Co. (NYSE:JPM) Price Target Increased to $230.00 by Analysts at Piper Sandler
Next post O’Reilly Automotive, Inc. (NASDAQ:ORLY) Receives $1,116.93 Average PT from Brokerages